PBIO OTC
Pressure BioSciences, Inc.
1W: +0.0%
1M: -50.0%
3M: -71.4%
YTD: -60.0%
1Y: -60.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+28.9% ▲
Capital Expenditures
$7K
+63.9% ▲
Free Cash Flow
-$3M
+29.0% ▲
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$77K
+160.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$12M | -$16M | -$20M | -$16M | -$29M |
| Depreciation & Amort. | $124K | $127K | $110K | $120K | $112K |
| Stock-Based Comp. | $1M | $489K | $255K | $215K | $7M |
| Change in Working Capital | $1M | $4M | $202K | $3M | $309K |
| Other Non-Cash Items | $2M | $7M | $15M | $8M | $19M |
| Operating Cash Flow | -$6M | -$5M | -$5M | -$4M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$23K | -$2K | -$123K | -$21K | -$7K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$795K | $0 | $0 | $0 |
| Investing Cash Flow | -$23K | -$797K | -$123K | -$21K | -$7K |
| — Financing Activities — | |||||
| Net Debt Issuance | $3M | $6M | $4M | $4M | $3M |
| Stock Repurchased | -$3.1B | $0 | -$7.1B | $0 | $0 |
| Dividends Paid | -$205M | -$300M | -$184M | -$386M | $0 |
| Other Financing | $205M | $300M | $184M | $386M | $325K |
| Financing Cash Flow | $6M | $6M | $5M | $4M | $3M |
| Net Change in Cash | -$73K | -$11K | $114K | -$128K | $77K |
| Cash End of Period | $30K | $19K | $132K | $4K | $81K |
| Free Cash Flow | -$6M | -$5M | -$5M | -$4M | -$3M |